Search Results - "Zagari, M J"

A cost analysis of diabetic lower-extremity ulcers by HARRINGTON, C, ZAGARI, M. J, COREA, J, KLITENIC, J

“…A cost analysis of diabetic lower-extremity ulcers. C Harrington , M J Zagari , J Corea and J Klitenic Lewin Group, Falls Church, Virginia 22042, USA…”
Get full text

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa by Patrick, D.L, Gagnon, D.D, Zagari, M.J, Mathijs, R, Sweetenham, J

“…Health-related quality of life (HrQOL) assessments are gaining importance as outcome measures in cancer clinical trials. A recently published clinical trial…”
Get full text

Evaluation of Quality of Life in a Clinical Trial with Nonrandom Dropout: The Effect of Epoetin Alfa in Anemic Cancer Patients by Fairclough, D. L., D. D. Gagnon, M. J. Zagari, N. Marschner, M. Dicato

“…Quality of life (QOL) endpoints from a randomized, placebo-controlled trial of anemic cancer patients treated with nonplatinum-containing chemotherapy who…”
Get full text

Pharmacoeconomics of chronic nonmalignant pain by Zagari, M J, Mazonson, P D, Longton, W C

“…Pain is one of the most common reasons for patients to seek medical care. In most settings, the model of acute pain treatment, with its emphasis on…”
Get full text

Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant

“…ABSTRACT Fatigue can be a major problem for cancer patients receiving chemotherapy, and anaemia is known to be an important contributory factor. Several…”
Get full text

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease by PARFREY, Patrick S, FOLEY, Robert N, WITTREICH, Barbara H, SULLIVAN, Daniel J, ZAGARI, Martin J, FREI, Dieter

“…It is unclear whether physiologic hemoglobin targets lead to cardiac benefit in incident hemodialysis patients without symptomatic heart disease and left…”
Get full text

Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients

“…ABSTRACT Anaemia is a common problem for cancer patients and often causes fatigue and reduces quality of life (QoL). Although randomised trials have repeatedly…”
Get full text

Epoetin Alfa Treatment Results in Clinically Significant Improvements in Quality of Life in Anemic Cancer Patients When Referenced to the General Population by CELLA, David, ZAGARI, Martin J, VANDOROS, Christina, GAGNON, Dennis D, HURTZ, Hans-Jürgen, NORTIER, Johan W. R

“…Anemia, highly common among cancer patients, is often an underlying cause of cancer-related fatigue and other quality-of-life (QOL) deficits. Although…”
Get full text

Benefits of epoetin alfa for cancer patients' quality of life are confirmed after modelling to account for missing data

“…ABSTRACT Incomplete data are inevitable in quality-of-life (QoL) studies involving cancer patients, since a proportion of patients will not complete the trial…”
Get full text